– Demonstrating a Favorable Safety Profile, Robust Immunogenicity, and Promising Preliminary Efficacy Apr 20, Everest Medicines Limited announced that the first-in-human (FIH) clinical trial data of EVM16, a proprietary personalized…
Avantor, Inc., a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries, announced that Avantor India has been…
Guoyuan International issued a research report on Essex Bio-Technology on 1 April 2026. Essex posted steady operating performance growth in 2025 and kicked off its international expansion, as the Phase…
Across the landscape of global biotech companies, the appointment of a senior executive often serves as a “barometer”—offering insights into a company’s pipeline potential and reflecting how industry veterans gauge…
China’s 2026 Report on the Work of the Government identified biopharmaceuticals as an emerging pillar industry, underscoring a supportive policy environment for innovative drugmakers. In this context, CanSino Biologics Inc.…
– Annual sales of HuaTangNing exceeded 4 million packs, a year-on-year increase of 91%, with revenues reaching RMB 492.9 million, a year-on-year increase of 93%, marking outstanding results from the…
– Innovation and R&D Advance Steadily, RMB 31.83 Billion in Revenue Recorded – Underlying Profit Attributable to Owners of the Parent of RMB 4.54 Billion Recorded Development Highlights – During…
On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13.02% year-on-year…
SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group; HKG: 03681) is pleased to announce its annual results for the year ended 31 December 2025 (the…
– Multiple Regulatory Approvals and Strategic Collaborations Strengthened Market Position Key Results Highlights: – Revenue Growth: 8.6% increase to approximately HK$1,813.8 million – Net Profit Increase: 3.5% rise to HK$318.1…
– Exhibition space fully secured prior to the show, reflecting strong exhibitor confidence in Northern Vietnam’s laboratory and scientific markets – Over 150 international and local exhibitors & brands confirmed…
CanSino Biologics Inc. (688185.SH/06185.HK) announced that the Company has obtained the Notification of Approval of Supplemental Drug Application issued by the National Medical Products Administration of China (the NMPA), pursuant…
Bioxytran, Inc. (OTCQB: BIXT), a clinical-stage biotechnology company developing breakthrough antiviral treatments, today announced it has initiated a research collaboration with the University of Georgia (UGA) as part of a…
Essex Bio-Technology Limited (EssexBio or the Company; HKG: 1061) today announces its successful participation in the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO 2026), held from 5 to 8 February…
According to disclosure of interests filed with the Hong Kong Stock Exchange (HKEX), the Government of Singapore Investment Corporation (GIC) has acquired an initial stake in Ascletis Pharma (HKG: 1672).…
Everest Medicines today announced that China’s National Medical Products Administration (NMPA) has approved VELSIPITY(R) (etrasimod arginine tablets) for the treatment of adult patients with moderately to severely active ulcerative colitis…
Everest Medicines (HKG: 1952, Everest, or the Company), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into…
Industry recognition for the third consecutive year reinforces AGFA HealthCare’s clinician-first commitment, and leadership in empowering connected, high-performance imaging environments AGFA HealthCare today announced that it has been named Best…
In Vienna, Enterprise Imaging offers the “Clinician-First” approach to keeping radiologists in their flow, spotlighting the human behind the innovation and empowering them to work in comfort with their technology.…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, announced the appointment of Gladys Wang as Vice President,…
